| Structure | Chemical Name | CAS | MF |
|
FMOC-D-CYS-OH
|
157355-80-1
|
C18H17NO4S
|
|
FMOC-D-THR-OH
|
157355-81-2
|
C19H19NO5
|
|
4-(1-Methylethenyl)-2-propyl-1H-Imidazole-5-carboxylic acidethylester
|
157356-73-5
|
C12H18N2O2
|
|
OlMesartan MedoxoMil iMpurity V
|
157356-74-6
|
C45H42N6O2
|
|
2-Chloro-6-fluorophenacyl bromide 98%
|
157359-99-4
|
C8H5BrClFO
|
|
4-Pyridinecarboxylicacid,3-(2-propenylamino)-,ethylester(9CI)
|
157361-40-5
|
C11H14N2O2
|
|
3-Pyridinecarboxylicacid,2-(2-propenylamino)-,methylester(9CI)
|
157362-04-4
|
C10H12N2O2
|
|
3-[4-(N-Ethyl-N-ethylhexylamino)phenyl]-4-cyano-5-dicyanomethylidene-2-oxo-2,5- dihydropyrrole
|
157362-95-3
|
C24H27N5O
|
|
2-PHENYL-2-TRIFLUOROMETHYLCYCLOHEXANONE
|
157364-44-8
|
C13H13F3O
|
|
AKOS BH-2115
|
157366-46-6
|
C14H11N
|
|
3-Chloro-6-Methoxy-benzo[d]isoxazole
|
157368-32-6
|
C8H6ClNO2
|
|
1,2-Benzisoxazol-3-amine,6-methoxy-(9CI)
|
157368-82-6
|
C8H8N2O2
|
|
1,2-Benzisoxazol-3-amine,5-methoxy-(9CI)
|
157368-84-8
|
C8H8N2O2
|
|
(R)-(-)-IBUPROFEN, (S)-(+)-LYSINATE
|
157369-85-2
|
C19H32N2O4
|
|
1,2-Cyclohexanediamine,4-(1-methylethyl)-(9CI)
|
157369-98-7
|
C9H20N2
|
|
2H-Benzimidazol-2-one,1,3-dihydro-4-(2-methylpropyl)-(9CI)
|
157369-99-8
|
C11H14N2O
|
|
4-Pyridinemethanol,alpha-ethyl-,(alphaS)-(9CI)
|
157371-07-8
|
C8H11NO
|
|
3-(BROMOMETHYL)-2,4, 10-TRIOXAADAMANTANE
|
157371-80-7
|
C8H11BrO3
|
|
7-Oxabicyclo[4.1.0]hept-2-ene, 2-methyl-
|
157372-14-0
|
C7H10O
|
|
Carbamic acid, (5-methyl-1,3-hexadienyl)-, 1,1-dimethylethyl ester (9CI)
|
157372-81-1
|
C12H21NO2
|
|
Carbamic acid, 2,4-pentadienyl-, 1,1-dimethylethyl ester (9CI)
|
157372-85-5
|
C10H17NO2
|
|
Carbamic acid, (3-methyl-1,3-butadienyl)-, 1,1-dimethylethyl ester (9CI)
|
157372-90-2
|
C10H17NO2
|
|
Carbamic acid, (4-cyclopropyl-1,3-butadienyl)-, 1,1-dimethylethyl ester (9CI)
|
157372-92-4
|
C12H19NO2
|
|
RARECHEM AL BI 1384
|
157372-95-7
|
C10H8F2O3
|
|
1-Cyclopropyl-7-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
|
157372-99-1
|
C13H10FNO3
|
|
3-CHLORO-2,4-DIFLUOROBENZOYL CHLORIDE
|
157373-00-7
|
C7H2Cl2F2O
|
|
2,3,4-TRIFLUOROBENZOYL CHLORIDE
|
157373-08-5
|
C7H2ClF3O
|
|
2-BROMO-3-PYRIDYL TRIFLUOROMETHANESULFO&
|
157373-97-2
|
C6H3BrF3NO3S
|
|
D-myo-Inositol-1,4,6-triphosphate (sodium salt)
|
157380-18-2
|
C6H16NaO15P3
|
|
CHX-A''-DTPA(B-355)
|
157380-45-5
|
C26H34N4O10S
|
|
Azacyclotridecan-2-one, polymer with oxirane, block
|
157380-65-9
|
C14H27NO2
|
|
TAK 044
|
157380-72-8
|
C45H51N9O11S.2Na
|
|
4-O-BENZYL-D-GALACTAL,
|
157380-76-2
|
C13H16O4
|
|
(S)-2-Amino-2-methyl-4-phosphonobutanoic acid
|
157381-42-5
|
C5H12NO5P
|
|
RPI 856 A
|
157381-54-9
|
C43H61N7O13
|
|
RPI 856 C
|
157381-55-0
|
C39H56N6O10
|
|
AC-ASP-TYR(PO3H2)-VAL-PRO-MET-LEU-NH2
|
157382-69-9
|
C36H56N7O13PS
|
|
Carbamic acid, [(1S,2S)-2-hydroxy-1-methylpropyl]-, 1,1-dimethylethyl ester
|
157394-45-1
|
C9H19NO3
|
|
Carbamic acid, [(1S,2R)-2-hydroxy-1-methylpropyl]-, 1,1-dimethylethyl ester
|
157394-46-2
|
C9H19NO3
|
|
1H-1,2,4-Triazole,3-chloro-1-(chloromethyl)-(9CI)
|
157395-52-3
|
C3H3Cl2N3
|
|
3-Pyridinecarboxylicacid,6-(propylidenehydrazino)-(9CI)
|
157398-26-0
|
C9H11N3O2
|
|
Butanamide, 4-(dimethylamino)- (9CI)
|
157400-29-8
|
C6H14N2O
|
|
6-(4-fluorophenyl)pyridine-2-carbaldehyde
|
157402-44-3
|
C12H9NO
|
|
1,2-Ethanediol,1-(2-ethylphenyl)-(9CI)
|
157403-39-9
|
C10H14O2
|
|
BACOSIDE A3(P)
|
157408-08-7
|
C47H76O18
|
|
2-ethoxy-1-isocyano-2-methyl-propane, technetium
|
157409-47-7
|
C42H78N6O6Tc
|
|
[[(3,4,5-Trimethyl-1H-pyrrol-2-yl)(3,4,5-trimethyl-2H-pyrrol-2-ylidene)methyl]carbonitrile](difluoroborane)
|
157410-23-6
|
C16H18BF2N3
|
|
shinflavanone
|
157414-03-4
|
C25H26O4
|
|
Taxuspine B
|
157414-05-6
|
C35H42O10
|
|
Methyl 2-broMo-2-fluoropropanoate
|
157415-07-1
|
C4H6BrFO2
|
|
MORPHOLINOFORMAMIDINE HYDROBROMIDE
|
157415-17-3
|
C5H12BrN3O
|
|
Benzene, 1,3-diisocyanatomethyl-, homopolymer, polypropylene glycol mono-Bu ether- and 2-pyridineethanol-blocked
|
157420-46-7
|
|
|
Spiro[cyclopropane-1,6(7H)-[1H,3H,5H]pyrazolo[1,2-c][1,3,4]thiadiazole] (9CI)
|
157420-50-3
|
C7H12N2S
|
|
2H-[1,2,4]Triazino[5,4-c][1,2,4]triazine(9CI)
|
157420-78-5
|
C5H5N5
|
|
Carbamic acid, 2,4-pentadienyl-, 1,1-dimethylethyl ester, (E)- (9CI)
|
157424-76-5
|
C10H17NO2
|
|
Methyl 5-acetyl-4-bromo-1H-pyrrole-2-carboxylate
|
157425-54-2
|
C8H8BrNO3
|
|
2-Propanone, 1-(tetrahydro-5-methyl-2-furanyl)-, cis- (9CI)
|
157427-19-5
|
C8H14O2
|
|
2-Propanone, 1-(tetrahydro-5-methyl-2-furanyl)-, trans- (9CI)
|
157427-20-8
|
C8H14O2
|
|
2-Propanone, 1-(tetrahydro-3-methyl-2-furanyl)-, cis- (9CI)
|
157427-26-4
|
C8H14O2
|
|
2-Propanone, 1-(tetrahydro-3-methyl-2-furanyl)-, trans- (9CI)
|
157427-27-5
|
C8H14O2
|
|
N-Methylindole-2-tributylstannane
|
157427-46-8
|
C21H35NSn
|
|
1-methyl-2-o-tolyl-1H-indole
|
157427-49-1
|
C16H15N
|
|
2-Cyclohexen-1-one,5-(hydroxymethyl)-3-(1-methylethoxy)-(9CI)
|
157427-99-1
|
C10H16O3
|
|
2-(16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoic acid (non-preferred name)
|
157428-39-2
|
C25H17NO4
|
|
3,4-DICHLORO-4'-FLUOROBENZOPHENONE
|
157428-51-8
|
C13H7Cl2FO
|
|
4-(4-Fluoro-phenyl)-oxazol-2-ylaMine
|
157429-08-8
|
C9H7FN2O
|
|
(R)-4-Mercapto-2-pyrrolidone
|
157429-42-0
|
C4H7NOS
|
|
N,N-Dimethyl-L-Alanine
|
157431-09-9
|
C5H11NO2
|
|
2-Azetidinone,3-amino-1-(1-propenyl)-(9CI)
|
157431-96-4
|
C6H10N2O
|
|
2-Azetidinone,3-amino-1-(2-hydroxyethenyl)-(9CI)
|
157431-98-6
|
C5H8N2O2
|
|
2-Azetidinone,3-amino-1-(1-buten-3-ynyl)-(9CI)
|
157432-01-4
|
C7H8N2O
|
|
2-Azetidinone,3-amino-1-(2-fluoroethenyl)-(9CI)
|
157432-02-5
|
C5H7FN2O
|
|
2-Azetidinone,3-amino-1-(1-buten-3-ynyl)-4-methyl-,cis-(9CI)
|
157432-10-5
|
C8H10N2O
|
|
2-Azetidinone,3-amino-1-(2-fluoroethenyl)-4-hydroxy-,cis-(9CI)
|
157432-20-7
|
C5H7FN2O2
|
|
3-(2-CHLORO-PHENYL)-PROPIONALDEHYDE
|
157433-36-8
|
C9H9ClO
|
|
2-(4-((7-CHLORO-2-QUINOXALINYL)OXY)-PHENOXY)-PROPIONIC ACID
|
157435-10-4
|
C17H13ClN2O4
|
|
5-(TERT-BUTYL)-2-HYDROXYISOPHTHALIC ACID
|
157436-33-4
|
C12H14O5
|
|
1H-Pyrazole-4-carboxylicacid,5-amino-1-(2,3-dihydroxypropyl)-(9CI)
|
157436-82-3
|
C7H11N3O4
|
|
1,3-Benzodioxole-4-methanol, 2,2-difluoro-
|
157437-25-7
|
C8H6F2O3
|
|
5-CHLORO-8-QUINOLINETRIFLUOROMETHANESUL&
|
157437-38-2
|
C10H5ClF3NO3S
|
|
Ethanone, 1-[4-(1-fluoroethenyl)phenyl]- (9CI)
|
157437-39-3
|
C10H9FO
|
|
2-Pyrrolidinone, 1-[(2-thioxo-1-piperidinyl)methyl]-
|
157439-25-3
|
C10H16N2OS
|
|
2-Pyrrolidinone, 1-[(hexahydro-2-thioxo-1H-azepin-1-yl)methyl]-
|
157439-26-4
|
C11H18N2OS
|
|
2-Piperidinone, 1-[(2-thioxo-1-pyrrolidinyl)methyl]-
|
157439-31-1
|
C10H16N2OS
|
|
2-Piperidinone, 1-[(2-thioxo-1-piperidinyl)methyl]-
|
157439-33-3
|
C11H18N2OS
|
|
2H-Azepin-2-one, hexahydro-1-[(2-thioxo-1-pyrrolidinyl)methyl]-
|
157439-35-5
|
C11H18N2OS
|
|
2-Pyrrolidinethione, 1-[[(trimethylsilyl)oxy]methyl]-
|
157439-39-9
|
C8H17NOSSi
|
|
2-Pyrrolidinethione, 1-[1-[(trimethylsilyl)oxy]ethyl]-
|
157439-40-2
|
C9H19NOSSi
|
|
|
1-(3'-nido-carboranyl-2'-hydroxy)propyl-2-nitroimidazole
|
157442-52-9
|
|
|
5-o-carboranyl-1-(2-deoxy-2-fluoro-arabinofuranosyl)uracil
|
157444-53-6
|
C11H10B10FN2O5*
|
|
2-(4-tert-Butyl-phenyl)-2-Methyl-propionic acid Methyl ester
|
157444-69-4
|
C15H22O2
|
|
1H-Thieno[3,4-d]iMidazole-4-pentanaMide, hexahydro-2-oxo-N-(4-pyridinylMethyl)-, (3aS,4S,6aR)-
|
157446-76-9
|
C16H22N4O2S
|
|
VD1-RPD2 neuropeptide alpha2
|
157452-74-9
|
C123H196N44O38S3
|
|
TRANS-2-FLUORO-4-(4-VINYL-CYCLOHEXYL)-BENZONITRILE
|
157453-50-4
|
C15H16FN
|
|
2,3-di-(4-nitrophenyl)-5-t-butyl-2H-tetrazolium
|
157458-76-9
|
C17H17ClN6O4
|
|
1-Piperazinecarboxamide,4-(2-propenyl)-(9CI)
|
157459-51-3
|
C8H15N3O
|
|
Imidazo[2,1-b]thiazole-6-carboxylic acid, 2,3-dihydro-, ethyl ester (9CI)
|
157459-68-2
|
C8H10N2O2S
|
|
Imidazo[2,1-b]thiazole-6-carboxaldehyde, 2,3-dihydro- (9CI)
|
157459-71-7
|
C6H6N2OS
|
|
TRI(CHLORO)DI(PYRIDYL)(TERTBUTYLIMIDO)TANTALUM
|
157464-07-8
|
C14H19Cl3N3Ta
|
|
2-Cyclobuten-1-one, 3-amino-2-phenyl-
|
157464-27-2
|
C10H9NO
|